BMEA Biomea Fusion, Inc.
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidat…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
 After Golden Cross, Biomea Fusion, Inc. (BMEA)'s Technical Outlook is Bright Good things could be on the horizon when a stock experiences a golden cross event. How should investors react? | ||
Sector Update: Healthcare Stocks Softer Late Afternoon Healthcare stocks decreased late Monday afternoon, with the NYSE Healthcare Index and the State Stre | ||
 Citi Predicts Up to 410% Rally for These 2 ‘Strong Buy’ Stocks With the third quarter well underway and most second-quarter earnings now in the rearview mirror, investors are starting to look ahead to the rest of 2026 and how best to position their portfolios.Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks The good news is that the latest earning | ||